Evaluation Of Hepatic Impairment On AG-013736 Pharmacokinetics
Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the effects of mild and moderate impairment of hepatic function on
the single-dose pharmacokinetics, safety and tolerability of AG-013736.